Intravenous immunoglobulin to treat neonatal alloimmune haemolytic disease

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 25, Issue 12, 2012, Pages 2782-2785

  Corvaglia, Luigi ^a   Legnani, Elena ^a   Galletti, Silvia ^a   Arcuri, Santo ^a   Aceti, Arianna ^a   Faldella, Giacomo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Exchange transfusion; Intravenous immunoglobulin; Newborn; Rhesus haemolytic disease

Indexed keywords

IMMUNOGLOBULIN; INTRATECT; UNCLASSIFIED DRUG;

BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; EXCHANGE BLOOD TRANSFUSION; FEMALE; HEMOLYTIC ANEMIA; HOSPITALIZATION; HUMAN; INTRAVENOUS CATHETER; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NECROTIZING ENTEROCOLITIS; NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; NEUROLOGIC DISEASE; NEWBORN; NEWBORN HEMOLYTIC DISEASE; PHOTOTHERAPY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RISK REDUCTION;

ANEMIA, HEMOLYTIC, AUTOIMMUNE; BIRTH WEIGHT; COHORT STUDIES; ENTEROCOLITIS, NECROTIZING; ERYTHROBLASTOSIS, FETAL; EXCHANGE TRANSFUSION, WHOLE BLOOD; FEMALE; GESTATIONAL AGE; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULINS, INTRAVENOUS; INFANT, NEWBORN; MALE; RETROSPECTIVE STUDIES; RH ISOIMMUNIZATION; TREATMENT OUTCOME;

EID: 84870345901     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2012.718387     Document Type: Review

References (18)

1. Mundy CA. Intravenous immunoglobulin in the management of hemolytic disease of the newborn. Neonatal Netw 2005;24:17-24.
2. Eder AF. Update on HDFN: new information on long-standing controversies. Immunohematology 2006;22:188-195. (Pubitemid 46239723)
3. Greenough A. Rhesus disease: postnatal management and outcome. Eur J Pediatr 1999;158:689-693. (Pubitemid 29390103)
4. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297-316.
5. Alcock GS, Liley H. Immunoglobulin infusion for isoimmune haemolytic jaundice in neonates. Cochrane Database Syst Rev 2002:CD003313.
6. Smits-Wintjens VE, Walther FJ, Rath ME, Lindenburg IT, te Pas AB, Kramer CM, Oepkes D, et al. Intravenous immunoglobulin in neonates with rhesus hemolytic disease: a randomized controlled trial. Pediatrics 2011;127:680-686.
7. Navarro M, Negre S, Matoses ML, Golombek SG, Vento M. Necrotizing enterocolitis following the use of intravenous immunoglobulin for haemolytic disease of the newborn. Acta Paediatr 2009;98:1214-1217.
8. Figueras-Aloy J, Rodriguez-Miguelez JM, Iriondo-Sanz M, Salvia- Roiges MD, Botet-Mussons F, Carbonell-Estrany X. Intravenous immunoglobulin and necrotizing enterocolitis in newborns with hemolytic disease. Pediatrics 2010;125:139-144.
9. Polacek K. Additional experience with indications for exchange transfusion based on the bilirubin level. Cesk Ped 1967;22:471-476.
10. Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics 1999;103:6-14. (Pubitemid 29281921)
11. Johnson L, Bhutani VK. Guidelines for management of the jaundiced term and near-term infant. Clin Perinatol 1998;25:555-74, viii.
12. Alpay F, Sarici SU, Okutan V, Erdem G, Ozcan O, Gokcay E. High-dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice. Acta Paediatr 1999;88:216-219. (Pubitemid 29124328)
13. Dagoglu T, Ovali F, Samanci N, Bengisu E. High-dose intravenous immunoglobulin therapy for rhesus haemolytic disease. J Int Med Res 1995;23:264-271.
14. Rubo J, Albrecht K, Lasch P, Laufkotter E, Leititis J, Marsan D, Niemeyer B et al. High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease. J Pediatr 1992;121:93-97, http://www.ncbi.nlm. nih.gov/pubmed/1306646.
15. Voto LS, Sexer H, Ferreiro G, Tavosnanska J, Orti J, Mathet ER, Margulies M, Margulies M. Neonatal administration of high-dose intravenous immunoglobulin in rhesus hemolytic disease. J Perinat Med 1995;23:443-451. (Pubitemid 26052734)
16. Huizing K, Roislien J, Hansen T. Intravenous immune globulin reduces the need for exchange transfusions in Rhesus and AB0 incompatibility. Acta Paediatr 2008;97:1362-1365.
17. Gottstein R, Cooke RW. Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn. Arch Dis Child Fetal Neonatal Ed 2003;88:F6-10.
18. Jackson JC. Adverse events associated with exchange transfusion in healthy and ill newborns. Pediatrics 1997;99:E7.